Study of non-infectious eye inflammation and treatment needs
Part of Eyes & vision clinical trials.
This study follows adults with non-infectious uveitis (intermediate, posterior, or pan-uveitis) to better understand inflammation activity and treatment needs. It also follows adults having planned eye surgery (like cataract or vitreoretinal surgery) to compare groups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- If you have uveitis: it is non-infectious (not caused by an infection)
- Your uveitis is intermediate, posterior, or affects the whole eye (panuveitis)
- Your eye inflammation is active enough to need treatment (steroid shots/pills or immune-suppressing or biologic medicines)
- You have health insurance and can sign consent to join
- If you are a surgery participant: your cataract or vitreoretinal surgery is planned (not urgent)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of two medications (adalimumab and mycophenolate mofetil) to reduce eye inflammation in people with uveitis that requires steroids. It aims to help patients use less steroid medication while keeping their uveitis under control.
This trial tests a new cell therapy called TRX103 for people with active uveitis not caused by an infection. It aims to see if the treatment is safe and helps reduce eye inflammation.
This study follows people who have been diagnosed with uveitis (inflammation inside the eye). It helps researchers better understand the condition and how people do over time.
This study looks at children with long-term eye inflammation that is not caused by an infection. It aims to learn more about the condition and how to better help patients.
This study uses a special eye scan (OCT) to measure and classify inflammatory cells inside the eye. It aims to better understand different types of uveitis and improve diagnosis and treatment.
This trial looks at how often inflammatory flare-ups happen in patients with a type of eye inflammation called posterior uveitis. It focuses on people who have been treated with a fluocinolone acetonide implant, a tiny device placed in the eye that releases medicine over time, and aims to understand how well it controls inflammation.
Hear when a new Non Infectious Uveitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.